Progression and management of chronic heart failure

Area of Science:

• Cardiology
• Clinical Medicine
• Medical Classification Systems

Background:

• Current heart failure (HF) therapeutic guidelines rely on the American College of Cardiology (ACC) and American Heart Association (AHA) 4-stage classification (A-D).
• This classification progresses from risk factors (A) to structural heart disease (B), symptoms (C), and finally, low cardiac output (D).
• While Stage D has clear implications, Stages A-C lack distinct therapeutic targets, potentially delaying diagnosis and optimal treatment.

Purpose of the Study:

• To propose a revised, more clinically actionable 3-stage classification for chronic heart failure (CHF).
• To address the limitations of the current ACC/AHA staging system in guiding therapy for Stages A-C.
• To facilitate improved CHF management by non-specialists through clearer therapeutic targets.

Main Methods:

• Critically evaluated the existing 4-stage ACC/AHA classification for chronic heart failure (CHF).
• Proposed a new 3-stage classification system based on distinct pathophysiological states.
• Focused on identifying stages with clear therapeutic implications for clinical practice.

Main Results:

• The current 4-stage ACC/AHA classification offers limited therapeutic guidance for Stages A, B, and C.
• The proposed 3-stage system comprises: 1) Left Ventricular (LV) remodeling, 2) Clinical Heart Failure, and 3) Low Cardiac Output State.
• This revised classification provides precise therapeutic targets at each stage.

Conclusions:

• The proposed 3-stage classification (LV remodeling, clinical HF, low cardiac output) offers superior clarity for therapeutic intervention in CHF.
• This revised system aims to simplify and enhance the management of patients with chronic heart failure.
• It is expected to improve diagnostic accuracy and treatment efficacy, particularly for non-experts.